A major institutional investor risked deploying capital into a bio-energy asset that faced imminent regulatory obsolescence. By mapping emerging EU directives, we forced a pivot to an alternative, compliant feedstock, ensuring the project remained subsidy-eligible and profitable while competitors were left with stranded infrastructure.